Nemaura Medical Inc
NMRD
Get informed when a big investor buys or sells
+ FollowMarket Cap$8.07K
Close$
Share Statistics
| Market cap | $8,070.00 |
|---|---|
| Enterprise Value | $20.70 Million |
| Dividend Yield | $- (-) |
| Earnings per Share | $-0.57 |
| Beta | 0.92 |
| Outstanding Shares | 28,899,402 |
Return
| Return on Equity | 35.32% |
|---|---|
| Return on Assets | -121.81% |
| Return on Invested Capital | 55.74% |
Valuation & Multiples
| P/E Ratio | 0 |
|---|---|
| PEG | 0 |
| Price to Sales | -0.0 |
| Price to Book Ratio | -0.0 |
| Enterprise Value to Revenue | -13.32 |
| Enterprise Value to EBIT | -2.08 |
| Enterprise Value to Net Income | -4 |
| Total Debt to Enterprise | 1.01 |
| Debt to Equity | -1.17 |
Revenue Sources
No data
Insider Trades
Last Earnings Call
Report Date
June 3, 2026
EPS Estimate
-
Average shareholder expectationRevenue Estimate
-
Average shareholder expectationNext Earnings Call
Expected Date
August 10, 2026
EPS Estimate
$-0.08
Average shareholder expectationRevenue Estimate
$200,000
Average shareholder expectationInstitutional Sentiment (Put/Call)
No data available for the latest quarter.
Institutional Ownership
No data available for the latest quarter.
ESG Score
No data
About Nemaura Medical Inc
25 employees
CEO: Dewan Chowdhury Nemaura Medical Inc. (NMRD) is a medical technology company developing micro-systems-based wearable diagnostic devices and currently commercializing sugarBEAT™, and proBEAT™. sugarBEAT®, a CE mark approved Class IIb medical device, is a ...